Document is current
Any future updates will be listed below
-
Authors
Akera, Seiji https://orcid.org/0000-0002-5971-1208
Novak, Peter https://orcid.org/0000-0003-2501-7397
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (1OT2HL156812-01)
FBRI (2022A018462)
Mona Taliaferro/Bay Shore Recycling
- License Information
-
More Information
Article History
Received: 30 September 2025
Accepted: 6 February 2026
First Online: 2 March 2026
Declarations
:
: PN is a current or previous shareholder of Moderna, Editas Medicine, Novavax, and Pfizer. PN received royalties from Oxford University Press and he is an advisor/independent contractor for the Dysimmune Diseases Foundation.
